The latest edition of EMJ Respiratory is out now, featuring coverage from the European Respiratory Society (ERS) Congress 2026.
Inside, explore how tozorakimab reduced COPD exacerbations by up to 34%, why breathlessness is about far more than the lungs, what’s driving preventable pneumococcal deaths in Nigeria, and much more.
Stay ahead of respiratory care in our newest issue.
The latest edition of EMJ Respiratory is out now, featuring coverage from the European Respiratory Society (ERS) Congress 2026.
Inside, explore how tozorakimab reduced COPD exacerbations by up to 34%, why breathlessness is about far more than the lungs, what’s driving preventable pneumococcal deaths in Nigeria, and much more.
Stay ahead of respiratory care in our newest issue.
